Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
Inhibitors of bruton's tyrosine kinase
No-Receipt date
2017-00618 - 16/02/2017
No-Filing date
20170400498 - 16/02/2017
No-Granting date
3091565 - 11/04/2017
No-EPO application date
12166300.9 - 28/12/2006
No-EPO granting date
2526771 - 30/11/2016
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
4/2017 - 03/07/2017
Expiration date
29/12/2026
Kind of title
Validation of European Patent
Legal status
VALID
Priorities
US826720 P22/09/2006/US
US828590 P06/10/2006/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A01N 43/90
A61K 31/519
A61P 35/00
C07D 487/04
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
1633278
PHARMACYCLICS LLC
1 N. WAUKEGAN ROAD, NORTH CHICAGO
ILLINOIS, U.S.A.
60064
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
1822721
HONIGBERG, LEE
1822722
VERNER, ERIK
1822723
PAN, ZHENGYING
Representatives
Code
Firstname
Surname
Address
Town
Zip
3458
ELENI
PAPAKONSTANTINOU "ELENI G. PAPAKOSTANTINOU KAI SYNERGATES, DIKIGORIKI ETAIRIA"
KOUMPARI 2
ATHINA (ATTIKIS)
10674
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
848
EFANGELIA
GIAZITZOGLOU - THOMAIDOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
GREECE
Owners History
Date
Description
Comments
Data before modification
Data after modification
28/03/2024
Αλλαγή Έδρας (7e805)
ΑΡ.ΠΡΩΤ. 9561/2024 (ΑΡ.ΥΠΟΘ. 4857225/2024) ΠΛΗΡΕΞ. ΔΙΚΗΓΟΡΟΣ ΜΑΡΙΑ ΑΘΑΝΑΣΙΑΔΟΥ (ΑΛΛΑΓΗ ΕΔΡΑΣ)
863673 Pharmacyclics LLC 995 East Arques Avenue ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Sunnyvale, CA 94085
1633278 Pharmacyclics LLC 1 N. Waukegan Road, North Chicago ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ ILLINOIS, U.S.A.
Title Instruments
Payments history
19 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).